1. Home
  2. ARI vs LQDA Comparison

ARI vs LQDA Comparison

Compare ARI & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARI
  • LQDA
  • Stock Information
  • Founded
  • ARI 2009
  • LQDA 2004
  • Country
  • ARI United States
  • LQDA United States
  • Employees
  • ARI N/A
  • LQDA N/A
  • Industry
  • ARI Real Estate Investment Trusts
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ARI Real Estate
  • LQDA Health Care
  • Exchange
  • ARI Nasdaq
  • LQDA Nasdaq
  • Market Cap
  • ARI 1.2B
  • LQDA 1.3B
  • IPO Year
  • ARI 2009
  • LQDA 2018
  • Fundamental
  • Price
  • ARI $9.67
  • LQDA $15.09
  • Analyst Decision
  • ARI Hold
  • LQDA Strong Buy
  • Analyst Count
  • ARI 4
  • LQDA 7
  • Target Price
  • ARI $9.08
  • LQDA $28.33
  • AVG Volume (30 Days)
  • ARI 1.2M
  • LQDA 941.3K
  • Earning Date
  • ARI 04-28-2025
  • LQDA 03-19-2025
  • Dividend Yield
  • ARI 10.35%
  • LQDA N/A
  • EPS Growth
  • ARI N/A
  • LQDA N/A
  • EPS
  • ARI N/A
  • LQDA N/A
  • Revenue
  • ARI $147,887,000.00
  • LQDA $13,996,000.00
  • Revenue This Year
  • ARI $29.85
  • LQDA $256.78
  • Revenue Next Year
  • ARI $1.28
  • LQDA $222.00
  • P/E Ratio
  • ARI N/A
  • LQDA N/A
  • Revenue Growth
  • ARI N/A
  • LQDA N/A
  • 52 Week Low
  • ARI $8.44
  • LQDA $8.26
  • 52 Week High
  • ARI $11.20
  • LQDA $16.81
  • Technical
  • Relative Strength Index (RSI)
  • ARI 42.68
  • LQDA 51.01
  • Support Level
  • ARI $9.66
  • LQDA $14.84
  • Resistance Level
  • ARI $9.85
  • LQDA $15.86
  • Average True Range (ATR)
  • ARI 0.19
  • LQDA 0.66
  • MACD
  • ARI -0.05
  • LQDA 0.03
  • Stochastic Oscillator
  • ARI 19.71
  • LQDA 67.37

About ARI Apollo Commercial Real Estate Finance Inc

Apollo Commercial Real Estate Finance Inc is a real estate investment trust that primarily originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: